DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Aghajanian C, Goff B, Nycum LR. et al.
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer.
Gynecol Oncol 2015;
139: 10-16
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.